text
"['\n1. 요약재무정보\n가. 요약 연결재무정보\xa0\n\xa0(1) 연결재무제표\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 (단위: 천원)\r\n구 분\n\xa0제 49 기 분기(감사 또는 검토를 받지않은 재무제표)\n\xa0제 48 기\n\xa0제 47 기\n2020년 분기말\n2019년말\n2018년말\n[비유동자산]\n63,027,736\n59,972,232\n59,510,515\n\xa0ㆍ유형자산\n35,749,935\n35,896,614\n36,811,402\n\xa0ㆍ사용권자산\n1,238,237\n1,350,630\n-\n\xa0ㆍ무형자산\n1,225,241\n1,355,047\n1,492,916\n\xa0ㆍ투자부동산\n-\n577,824\n583,763\n\xa0ㆍ매출채권 및 기타채권\n1,807,200\n1,799,646\n1,502,963\n\xa0ㆍ이연법인세자산\n4,837,504\n4,047,502\n4,119,429\n\xa0ㆍ반환제품회수권\n18,096,844\n14,823,394\n14,878,027\n\xa0ㆍ기타비유동금융자산\n72,775\n121,575\n122,015\n\xa0[유동자산]\n147,287,279\n134,032,372\n126,226,236\nㆍ재고자산\n47,871,596\n69,402,543\n63,751,910\nㆍ매출채권 및 기타채권\n91,102,756\n19,634,212\n15,813,476\nㆍ기타유동금융자산\n52,110\n748,692\n9,350\nㆍ현금 및 현금성자산\n8,260,817\n44,246,925\n46,651,500\n자산총계\n210,315,015\n194,004,604\n185,736,751\n[납입자본]\n9,575,638\n9,575,638\n9,575,638\n[이익잉여금]\n142,207,463\n134,954,531\n131,415,722\n[기타자본구성요소]\n(6,496,695)\n(7,909,274)\n(8,491,279)\n지배주주 자본소계\n145,286,406\n136,620,895\n132,500,081\n[비지배지분]\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\n559,961\n527,769\n500,337\n자본총계\n145,846,367\n137,148,664\n133,000,418\n[비유동부채]\n30,608,264\n25,663,990\n25,114,634\n[유동부채]\n33,860,384\n31,191,950\n27,621,699\n부채총계\n64,468,648\n56,855,940\n52,736,333\n2020.01.01~2020.09.30\n2019.01.01~2019.12.31\n2018.01.01~2018.12.31\n매출액\n117,786,307\n124,644,780\n121,108,495\n영업이익\n12,877,107\n7,799,137\n6,830,487\n연결당기순이익\n10,208,930\n6,466,935\n6,154,336\n지배지분 순이익\n10,176,737\n6,439,503\n6,132,832\n비지배지분 순이익\n32,193\n27,432\n21,504\n주당순이익\n866원\n555원\n529원\n연결에 포함된 회사수\n2\n2\n2\n(2) 연결대상 종속기업\xa01) 연결재무제표에 포함된 종속기업\n\xa0기업명\n소유지분율\n소재지\n결산일\n업종\n나노바이오(주)\n65.07%\n한국\xa0\n12월\n화학제품 ,금속분말 제조판매\n*K-IFRS 제 1110호에 따라 종속기업의 지분율이 과반 초과하여 연결대상이\xa0\xa0 됨.\n\xa02) 연결대상 종속기업의 요약재무정보\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 (단위: 천원)\xa0\xa0\n구 분\n2020년 분기(20기)\n2019년(19기)\n2018년(18기)\n자산\n1,625,614\n1,539,696\n1,604,787\n부채\n13,191\n6,956\n117,660\n자본\n1,612,423\n1,532,740\n1,487,127\n매출액\xa0\n443,947\n463,353\n332,488\n영업이익\n81,084\n34,490\n21,639\n당기순이익\n79,683\n45,613\n32,853\n* 나노바이오(주)의 재무제표는 감사 또는 검토를 받지 않은 재무제표입니다.\n나. 요약 재무정보\xa0\n\xa0(1) 재무제표\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 (단위: 천원)\n구 분\n\xa0제 49 기 분기(감사 또는 검토를 받지않은 재무제표)\n\xa0제 48 기\n\xa0제 47 기\n2020년 분기말\n2019년말\n2018년말\n[비유동자산]\n63,591,155\n60,532,211\n60,061,308\n\xa0ㆍ유형자산\n35,749,927\n35,896,606\n36,811,394\n\xa0ㆍ사용권자산\n1,238,237\n1,350,630\n-\n\xa0ㆍ무형자산\n1,225,241\n1,355,047\n1,492,916\n\xa0ㆍ투자부동산\n-\n577,824\n583,763\n\xa0ㆍ종속기업투자자산\n566,004\n566,004\n566,004\n\xa0ㆍ매출채권 및 기타채권\n1,807,200\n1,799,646\n1,502,963\n\xa0ㆍ이연법인세자산\n4,834,927\n4,041,485\n4,104,226\n\xa0ㆍ반환제품회수권\n18,096,844\n14,823,394\n14,878,027\n\xa0ㆍ기타비유동금융자산\n72,775\n121,575\n122,015\n\xa0[유동자산]\n145,582,563\n132,543,839\n124,716,842\nㆍ재고자산\n47,824,673\n69,343,693\n63,568,205\nㆍ매출채권 및 기타채권\n90,518,137\n19,620,755\n15,806,414\nㆍ기타유동금융자산\n52,110\n3,200\n9,350\nㆍ현금 및 현금성자산\n7,187,643\n43,576,191\n45,332,873\n자산총계\n209,173,718\n193,076,050\n184,778,150\n[납입자본]\n9,575,638\n9,575,638\n9,575,638\n[이익잉여금]\n141,730,478\n134,537,508\n131,051,929\n[기타자본구성요소]\n(6,496,695)\n(7,909,274)\n(8,491,279)\n자본총계\n144,809,421\n136,203,872\n132,136,288\n종속기업 투자주식의평가방법\n원가법\xa0 \xa0 \xa0\xa0 \n원가법\xa0 \xa0 \xa0\xa0 \n원가법\xa0 \xa0 \xa0\xa0 \n[비유동부채]\n30,638,264\n25,687,090\n25,137,734\n[유동부채]\n33,726,033\n31,185,088\n27,504,128\n부채총계\n64,364,297\n56,872,178\n52,641,862\n2020.01.01~2020.09.30\n2019.01.01~2019.12.31\n2018.01.01~2018.12.31\n매출액\n117,232,160\n124,071,228\n120,665,547\n영업이익\n12,775,837\n7,712,751\n6,771,398\n당기순이익\n10,116,775\n6,386,274\n6,094,914\n총포괄손익\n10,116,775\n6,386,274\n6,094,914\n주당순이익\n861원\n550원\n525원\n']"
